Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study. [electronic resource]
Producer: 20130111Description: 1201-10 p. digitalISSN:- 1461-7285
- Adult
- Antipsychotic Agents -- adverse effects
- Aripiprazole
- Atherosclerosis -- epidemiology
- Bipolar Disorder -- blood
- Cohort Studies
- Diagnostic and Statistical Manual of Mental Disorders
- Drug Monitoring
- Dyslipidemias -- chemically induced
- Female
- Humans
- Intention to Treat Analysis
- Male
- Middle Aged
- North America -- epidemiology
- Patient Dropouts
- Piperazines -- adverse effects
- Psychotic Disorders -- blood
- Quinolones -- adverse effects
- Risk Factors
- Schizophrenia -- blood
- Severity of Illness Index
- Thiazoles -- adverse effects
- Weight Loss -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.